Altratech

Clarecastle, Ireland Founded: 2013 • Age: 13 yrs
Next-generation molecular detection kits for viral diseases are developed.
Request Access

About Altratech

Altratech is a company based in Clarecastle (Ireland) founded in 2013 by Tim Cummins. It operates as a HealthTech. Altratech has raised $10.98 million across 10 funding rounds from investors including European Commission, Enterprise Ireland and European Union. Altratech offers products and services including Multi-Analyte Point-of-Care Diagnostics. Altratech operates in a competitive market with competitors including NeuMoDx, Kryptos Biotechnologies, Quantalife, Beijing Xinyi Biotechnology and SpinDiag, among others.

  • Headquarter Clarecastle, Ireland
  • Founders Tim Cummins
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Altratech Ltd
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $10.98 M (USD)

    in 10 rounds

  • Latest Funding Round
    $11.52 M (USD), Grant

    Oct 07, 2024

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Altratech

Altratech offers a comprehensive portfolio of products and services, including Multi-Analyte Point-of-Care Diagnostics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Innovative diagnostics for multiple analytes at point-of-care settings.

People of Altratech
Headcount 10-50
Employee Profiles 6
Employee Profiles
People
Tim Cummins
CTO & Co-Founder,
People
Yan Zhao
Senior R&D Engineer
People
Colin King
Senior Lead Engineer
People
Tara Dalton
CEO

Unlock access to complete

Funding Insights of Altratech

Altratech has successfully raised a total of $10.98M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $11.52 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 10
  • Last Round Grant — $11.5M
  • First Round

    (16 Apr 2014)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2024 Amount Grant - Altratech Valuation

investors

Dec, 2021 Amount Series A - Altratech Valuation Kernel Capital
Dec, 2021 Amount Debt – Venture - Altratech Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Altratech

Altratech has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, Enterprise Ireland and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity investments are directed toward multiple sectors.
Founded Year Domain Location
VC firm investing in the UK and the US
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Altratech

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Altratech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Altratech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Altratech

Altratech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuMoDx, Kryptos Biotechnologies, Quantalife, Beijing Xinyi Biotechnology and SpinDiag, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of a platform for low cost molecular testing
domain founded_year HQ Location
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
domain founded_year HQ Location
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
domain founded_year HQ Location
Micro-droplet digital PCR and diagnostic reagents are manufactured.
domain founded_year HQ Location
Point-of-care systems for screening drug-resistant pathogens are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Altratech

Frequently Asked Questions about Altratech

When was Altratech founded?

Altratech was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Altratech located?

Altratech is headquartered in Clarecastle, Ireland. It is registered at Clarecastle, County Clare, Ireland.

Who is the current CEO of Altratech?

Tara Dalton is the current CEO of Altratech.

Is Altratech a funded company?

Altratech is a funded company, having raised a total of $10.98M across 10 funding rounds to date. The company's 1st funding round was a Series A of $3.96M, raised on Apr 16, 2014.

What does Altratech do?

Altratech is engaged in developing advanced multi-analyte point-of-care diagnostics. The company operates within the healthcare sector, offering solutions for rapid and accurate medical testing. Its technology is showcased at global conferences like TRI-CON Precision-Medicine in San Diego, aiming to transform diagnostic capabilities for various medical conditions.

Who are the top competitors of Altratech?

Altratech's top competitors include NeuMoDx, ReadyGo and Quantalife.

What products or services does Altratech offer?

Altratech offers Multi-Analyte Point-of-Care Diagnostics.

Who are Altratech's investors?

Altratech has 7 investors. Key investors include European Commission, Enterprise Ireland, European Union, Claret Capital Partners, and Kernel Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available